Clinical Trial Update: To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN [NA]

View source ↗

Summary

A clinical trial comparing FK506 (tacrolimus) with IVC for Class III-IV lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• FK506 (tacrolimus)
• IVC

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Lupus Nephritis | NA | Status: COMPLETED